Digital Content 
NEWS #PharmaBuzz
10 Apr 2019
// John LaMattina FORBES
https://www.forbes.com/sites/johnlamattina/2019/04/10/the-biopharmaceutical-cartel-and-high-drug-prices/#4fb4c4e6533c
04 May 2016
// EJ Lane FIERCE ASIA
http://www.fiercepharma.com/pharma-asia/japan-s-pmda-reviews-hep-b-risk-link-to-hep-c-therapies
03 May 2016
// Michael Mezher RAPS
http://www.raps.org/Regulatory-Focus/News/2016/05/03/24862/FDA-Calls-for-Head-to-Head-Trials-in-Revised-Draft-Guidance-on-Hepatitis-C-Drugs/
31 Mar 2016
// Tracy Staton FIERCE PHARMA MARKETING
http://www.fiercepharmamarketing.com/story/gilead-meds-face-little-threat-hep-c-rivals-merck-bms-and-abbvie-analyst/2016-03-30
26 Feb 2016
// PR NEWSWIRE
http://www.prnewswire.com/news-releases/abbvie-receives-chmp-positive-opinion-for-viekirax-ombitasvirparitaprevirritonavir-tablets--exviera-dasabuvir-tablets-without-ribavirin-for-the-treatment-of-chronic-hepatitis-c-in-genotype-1b-patients-with-compensated-cir-300226929.html
17 Feb 2016
// Amrutha Penumudi REUTERS
http://www.reuters.com/article/us-gilead-sciences-fda-hepatitis-idUSKCN0VP1UQ
Share 